Skip to main content
eScholarship
Open Access Publications from the University of California

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240)

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View